ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
American Riviera Bancorp (QX)

American Riviera Bancorp (QX) (ARBV)

19.69
0.06
(0.31%)
Closed December 17 3:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
19.69
Bid
19.17
Ask
19.79
Volume
442
19.51 Day's Range 19.69
15.25 52 Week Range 20.00
Market Cap
Previous Close
19.63
Open
19.51
Last Trade
100
@
19.69
Last Trade Time
Financial Volume
US$ 8,672
VWAP
19.6204
Average Volume (3m)
15,390
Shares Outstanding
5,834
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
42.62M
Net Profit
73.86M

About American Riviera Bancorp (QX)

Sector
-
Industry
-
Headquarters
Santa Barbara, USA
Founded
-
American Riviera Bancorp (QX) is listed in the sector of the OTCMarkets with ticker ARBV. The last closing price for American Riviera Bancorp (QX) was US$19.63. Over the last year, American Riviera Bancorp (QX) shares have traded in a share price range of US$ 15.25 to US$ 20.00.

American Riviera Bancorp (QX) currently has 5,834 shares outstanding. The market capitalization of American Riviera Bancorp (QX) is US$114,521.42 .

ARBV Latest News

American Riviera Bank Reports Profits and Growth

American Riviera Bank (OTC Markets: ARBV) announced unaudited net income of $1,569,000 ($0.61 per share) for the year ended December 31, 2014, a 12% increase as compared to $1,401,000 ($0.55...

American Riviera Bank Expands Market Share

American Riviera Bank (OTC Markets: ARBV) announced today unaudited net income of $365,000 ($0.14 per share) for the third quarter ended September 30, 2014, a decrease from the $473,000...

American Riviera Bank Exceeds $200 Million in Assets

American Riviera Bank (OTC Markets: ARBV) announced today unaudited net income of $382,000 ($0.15 per share) for the second quarter ended June 30, 2014, and $668,000 ($0.26 per share) for...

American Riviera Bank Reports Strong Growth and Innovative Technology

American Riviera Bank (OTCBB:ARBV) announced today unaudited net income of $286,000 ($0.11 per share) for the first quarter ended March 31, 2014. The Bank’s focus on building...

American Riviera Bank Reports Record Year

American Riviera Bank (OTCBB: ARBV) announced unaudited net income of $1,401,000 ($0.55 per share) for the year ended December 31, 2013, a 17% increase as compared to $1,193,000 ($0.47 per...

American Riviera Bank Reports Strong Quarterly Profit

American Riviera Bank (OTCBB: ARBV) announced today unaudited net income of $473,000 ($0.19 per share) for the third quarter ended September 30, 2013, a 38% increase from the same quarter...

American Riviera Bank Reports Profitable Growth

American Riviera Bank (OTCBB: ARBV) announced today unaudited net income of $391,000 ($0.15 per share) for the quarter ended June 30, 2013 and $730,163 ($0.29 per share) for the six months...

American Riviera Bank Reports Profit and Opening of Montecito Branch

American Riviera Bank (OTCBB:ARBV) announced today unaudited net income of $339,000 ($0.13 per share) for the quarter ended March 31, 2013. Pre-tax income for the quarter increased 105% to...

American Riviera Bank Poised for Continued Growth

American Riviera Bank (OTCBB: ARBV) announced record pre-tax income for the year, which increased 113% to $1,971,000 at December 31, 2012, compared to $923,000 for the year...

American Riviera Bank Reports Record Quarterly Profit

American Riviera Bank (OTCBB: ARBV) reported record unaudited pre-tax income of $638 thousand ($0.25 per share) for the third quarter ending September 30, 2012, which represents...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.010.050813008130119.6819.719.5170619.66279235CS
40.190.97435897435919.52019.353207319.51583049CS
121.015.4068522483918.682018.681539019.50812026CS
263.387520.779021622516.30252016.151238718.70925829CS
523.0418.258258258316.652015.25827118.34245336CS
1561.466554558.047624989618.223445452013.51579417.85618082CS
2601.739224569.6888547562417.950775442010.17968025484516.56081147CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
IBKKFImining Technologies Inc (CE)
US$ 0.05
(4,999,900.00%)
833
WRCDFWirecard AG (CE)
US$ 0.01
(999,900.00%)
250
SLAAFSitios Latinoamerica SAB de CV (PK)
US$ 0.189
(94,400.00%)
21.85k
MIKPMike The Pike Productions Inc (CE)
US$ 0.0002
(19,900.00%)
520k
KBNTKubient Inc (CE)
US$ 0.0002
(19,900.00%)
1.48k
AMHGQAmergent Hospitality Group Inc (CE)
US$ 0.000001
(-100.00%)
76.67k
CLVRClever Leaves Holdings Inc (CE)
US$ 0.000001
(-100.00%)
240
NEPTFNeptune Wellness Solutions Inc (CE)
US$ 0.000001
(-100.00%)
3.72k
ORMTQOrmet Corp (CE)
US$ 0.000001
(-99.99%)
500k
RKIGFReko International Group Inc (PK)
US$ 0.0006
(-99.98%)
100
RDARRaadr Inc (PK)
US$ 0.001
(-28.57%)
320.76M
HMBLHUMBL Inc (PK)
US$ 0.0012
(-4.00%)
311.02M
MMEXMMEX Resources Corporation (PK)
US$ 0.0001
(9,900.00%)
265.88M
EARIEntertainment Arts Research Inc (PK)
US$ 0.0001
(0.00%)
213.32M
CGACCode Green Apparel Corp (PK)
US$ 0.0005
(-16.67%)
125.52M

Discussion

View Full Feed
JMoneyHoops JMoneyHoops 5 minutes ago
Verified profile! https://x.com/jmoney_hoops/status/1869205515588501520?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ
EATR
dstock07734 dstock07734 5 minutes ago
Yes
NWBO
KILLAZILLA KILLAZILLA 6 minutes ago
DILUTION IS THE MAIN EYESORE....

WITHOUT SUBSTANTIAL REVENUE IT'S A POS DILUTION SCAM......
TLRY
gitreal gitreal 6 minutes ago
...where would our country be without folks daring to dream?

Pretty sad that you can't tell the difference between a grifting penny stock CEO and a legit startup entrepreneur. Or, even worse, you do know the difference and you are pretending, just to help promote the scam. I think i
NBRI
flipper44 flipper44 7 minutes ago
Those people know we can still see them, right?
NWBO
awesomed007 awesomed007 7 minutes ago
If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.
RDAR
awesomed007 awesomed007 7 minutes ago
If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.
RDAR
Eatatjoes Eatatjoes 7 minutes ago
Paul Malec of Deer Park, NY
QOIL
fuagf fuagf 7 minutes ago
Yeps, yeps and yeps. Good ones.
NoMoDo NoMoDo 7 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175527881 Meeting announced for TODAY

Better yet. Read this closely:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175530469
Ybyra agreed to purchase a company in France. Giving Dividends.
HMBL
manibiotech manibiotech 7 minutes ago
Well if you read the link you posted yourself , they are tracking in almost every other country on the planet . Please see the table . They are giving projected global scope of what is going on
I have no problem with you posting that link every hour of that pleases you 
NWBO
1vman 1vman 8 minutes ago
*****🚽UBQU🚽 Kevin Lamb is the typical OTC CEO , pocketing money while share holders lose amost all their investment

So much for forbes and da T0P 10 Health innovators wow!

🤔HUZZAH ENOUGH SAID !!!🤔
UBQU
janice shell janice shell 9 minutes ago
First of all, Syria is not a big oil producer. So it's a stupid idea. Trump has put it forward because he thinks everything should be his.

And because he's a moron.

https://investorshub.advfn.com/uimage/uploads/2024/12/17/oage%5BJPEG_image.jpeg

I must so
HappyAlways HappyAlways 9 minutes ago
I am, as a Fannie shareholder, against any government action to dilute Fannie shareholders' interest. (1) The PSPA loan is no longer valid, given the NWS payments are way over the original 10% interest payments by $310B. (2) Any attempt to exercise the free warrant will be met with lawsuits, given t
FNMA
TheDane TheDane 10 minutes ago
Not only did it hold but it’s on the way back up.
SMCI
OnTrack444 OnTrack444 10 minutes ago
Might see a dime after the RS!  

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!!  Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!!  GLTY
HMBL
manibiotech manibiotech 11 minutes ago
Interesting for sure but not conclusive which he repeat every day 

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience 


NWBO
FACT-MASTER FACT-MASTER 12 minutes ago
Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i
CDMO
arizona1 arizona1 12 minutes ago
Never trumpers are hilarious and brilliant too.
jimr1717 jimr1717 14 minutes ago
“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is
SINT
NoMoDo NoMoDo 15 minutes ago
If we don't see a dime, I will be shocked.
HMBL
Slyhunter Slyhunter 15 minutes ago
I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is
TSLA
nfrequent nfrequent 15 minutes ago
Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/
RNVA
XMaster2023 XMaster2023 15 minutes ago
Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will
NWBO